Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03370926 : FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- 18 Years or older

- Histologically confirmed newly diagnosed glioblastoma or anaplastic astrocytoma

- Patients must have undergone surgery with macroscopic complete resection or incomplete
resection with residual disease less than 5 cm on MRI

- An MRI or a scan 48h after surgery should be available

- WHO = 2

- Indication for adjuvant radiotherapy

- Surgery must have been performed 45 days before the start of radiotherapy.

- Ability to understand and to give consent

Exclusion Criteria:

- Age < 18 Years.

- Prior radiation therapy to the brain

- Any usual formal indication against MRI (claustrophobia, metallic objects or implanted
medical devices in body: pacemaker, clips, prostheses ...)

- Allergic reaction to FET

- Pregnant women or nursing mothers

- Refusal to use effective contraception at study entry and throughout the study if
patient is of childbearing age.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03370926      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740